Stockscreener 앱 받기
29.52
0.37%
-0.11
시간 외 거래:
29.10
-0.42
-1.42%
Rigel Pharmaceuticals 주식(RIGL)의 최신 뉴스
Brokers Offer Predictions for RIGL Q1 Earnings - MarketBeat
Rigel Pharmaceuticals’ Fast Track Ambitions Face Significant FDA Uncertainty - TipRanks
This Fund Bet $20 Million on RAPT Therapeutics as Stock Surges 500% This Past Year and Buyout Offer Emerges - AOL.com
Rigel Pharmaceuticals (RIGL) EPS Spike On Non Cash Gains Challenges Bullish Narratives - simplywall.st
Rigel Pharmaceuticals (RIGL) Projects Revenue Decline for 2026 - GuruFocus
Rigel Pharma stock slides on 2026 outlook (RIGL:NASDAQ) - Seeking Alpha
Rigel Pharmaceuticals (NASDAQ:RIGL) Shares Gap DownWhat's Next? - MarketBeat
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $71 - 富途牛牛
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Rigel Pharmaceuticals Inc (RIGL) Q4 2025 Earnings Call Highlights: Record Net Income and Strategic Growth Initiatives - GuruFocus
Rigel Pharmaceuticals Q4 2025 Earnings Call Transcript - MarketBeat
How The Rigel Pharmaceuticals (RIGL) Story Is Shifting With New Targets And Pipeline Progress - Yahoo Finance
Rigel Pharmaceuticals (RIGL) Set to Report Q4 FY2025 Earnings After the Bell — Here’s What to Expect - AlphaStreet News
Cumberland (CPIX) Q4 2025 Earnings Call Transcript - AOL.com
Earnings call transcript: Rigel’s Q4 2025 shows robust growth - Investing.com Australia
Earnings call transcript: Rigel’s Q4 2025 shows robust growth By Investing.com - Investing.com South Africa
Rigel Pharmaceuticals, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:RIGL) 2026-03-03 - Seeking Alpha
RIGL: Record sales and net income in 2025, with strong growth outlook and pipeline progress for 2026 - TradingView
Rigel Pharmaceuticals (RIGL) Q4 Earnings Miss Estimates - Bitget
Rigel Pharma (RIGL) Earnings Call Transcript - Nasdaq
Rigel Pharmaceuticals Q4 Earnings Call Highlights - MarketBeat
Rigel Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Rigel Pharmaceuticals Q4 Earnings, Revenue Rise; 2026 Revenue Outlook Set - marketscreener.com
Rigel Pharmaceuticals (RIGL) Projects FY26 Revenue Growth - GuruFocus
Earnings Summary: Rigel Pharmaceuticals Q4 - Benzinga
Rigel Pharmaceuticals (NASDAQ:RIGL) Announces Earnings Results - MarketBeat
RIGL: Record 2025 revenue and net income, with 2026 outlook for continued growth and pipeline progress - TradingView
Rigel Pharmaceuticals reports Q4 EPS $13.54 with items, consensus $1.20 - TipRanks
Rigel (NASDAQ: RIGL) boosts blood cancer drug sales and advances pipeline - Stock Titan
Rigel: Q4 Earnings Snapshot - marketscreener.com
RIGL: Record 2025 revenue and net income, strong product growth, and positive 2026 outlook - TradingView
Rigel Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Rigel Provides Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - marketscreener.com
RIGL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Rigel Pharmaceuticals (RIGL) Set to Announce Q4 Earnings - GuruFocus
A Preview Of Rigel Pharmaceuticals's Earnings - Benzinga
(RIGL) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Implied Volatility Surging for Rigel Pharmaceuticals Stock Options - Nasdaq
RIGL.O Technical Analysis & Stock Price Forecast - Intellectia AI
Rigel Pharmaceuticals, Inc. (RIGL) Stock Analysis: Unpacking a 49% Potential Upside for Investors - DirectorsTalk Interviews
Rigel Pharmaceuticals Options See Significant Rise in Implied Volatility - Bitget
Walter Moos Sells 4,000 Shares of Rigel Pharmaceuticals (NASDAQ:RIGL) Stock - MarketBeat
Rigel (RIGL) director Moos exercises options and sells 4,000 shares - Stock Titan
Rigel Pharmaceuticals (RIGL) Earnings Expected to Grow: Should You Buy? - Finviz
IOVA vs. RIGL: Which Small-Cap Biotech Has More Upside Potential? - TradingView
Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update - The AI Journal
Rigel Pharmaceuticals (RIGL) Projected to Post Earnings on Tuesday - MarketBeat
Will Tavalisse continue to drive Rigel Pharmaceuticals' growth in 2026? - MSN
Rigel Pharmaceuticals (NASDAQ:RIGL) Upgraded at Zacks Research - Defense World
How interest rate cuts could boost Rigel Pharmaceuticals Inc. stock2025 Analyst Calls & Weekly Top Performers Watchlists - mfd.ru
Rigel Pharmaceuticals (NASDAQ:RIGL) Raised to Hold at Zacks Research - MarketBeat
Rigel (NASDAQ: RIGL) EVP awarded 19,430 RSU-linked common shares - Stock Titan
Will Tavalisse Continue to Drive Rigel Pharmaceuticals' Growth in 2026? - Yahoo Finance
Responsive Playbooks and the RIGL Inflection - Stock Traders Daily
RIGL Stock Rises 59% in a Year: Time to Buy, Hold or Sell? - Bitget
Why Rigel Pharmaceuticals Inc. stock is favored by top institutions2025 Winners & Losers & Long-Term Growth Portfolio Plans - mfd.ru
Reasons to Consider Rigel Pharmaceuticals (RIGL) as a Strong Momentum Stock: Is It Time to Buy? - Intellectia AI
3.69%
0.68%
자본화:
|
볼륨(24시간):